Orbimed Advisors as of Dec. 31, 2015
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 129 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 5.2 | $578M | 8.4M | 68.79 | |
| Amgen (AMGN) | 4.3 | $474M | 2.9M | 162.33 | |
| Boston Scientific Corporation (BSX) | 4.1 | $451M | 24M | 18.44 | |
| Allergan | 4.0 | $445M | 1.4M | 312.50 | |
| Biogen Idec (BIIB) | 4.0 | $442M | 1.4M | 306.35 | |
| Abbvie (ABBV) | 4.0 | $441M | 7.4M | 59.24 | |
| Celgene Corporation | 4.0 | $439M | 3.7M | 119.76 | |
| Alexion Pharmaceuticals | 3.9 | $434M | 2.3M | 190.75 | |
| Hca Holdings (HCA) | 3.6 | $403M | 6.0M | 67.63 | |
| Gilead Sciences (GILD) | 3.1 | $346M | 3.4M | 101.19 | |
| Incyte Corporation (INCY) | 2.8 | $307M | 2.8M | 108.45 | |
| Impax Laboratories | 2.6 | $285M | 6.7M | 42.76 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $262M | 483k | 542.87 | |
| Relypsa | 1.9 | $210M | 7.4M | 28.34 | |
| Health Net | 1.9 | $205M | 3.0M | 68.46 | |
| Wright Medical Group Nv | 1.8 | $199M | 8.2M | 24.18 | |
| Thermo Fisher Scientific (TMO) | 1.8 | $196M | 1.4M | 141.85 | |
| Express Scripts Holding | 1.7 | $191M | 2.2M | 87.41 | |
| Puma Biotechnology (PBYI) | 1.6 | $176M | 2.2M | 78.40 | |
| Mylan Nv | 1.6 | $171M | 3.2M | 54.07 | |
| Illumina (ILMN) | 1.5 | $168M | 877k | 191.95 | |
| Intercept Pharmaceuticals In | 1.5 | $167M | 1.1M | 149.35 | |
| Teva Pharmaceutical Industries (TEVA) | 1.4 | $161M | 2.4M | 65.64 | |
| Ophthotech | 1.4 | $158M | 2.0M | 78.53 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $142M | 2.5M | 56.57 | |
| Agilent Technologies Inc C ommon (A) | 1.3 | $139M | 3.3M | 41.81 | |
| Eli Lilly & Co. (LLY) | 1.2 | $136M | 1.6M | 84.26 | |
| Pfizer (PFE) | 1.2 | $133M | 4.1M | 32.28 | |
| Intuitive Surgical (ISRG) | 1.2 | $131M | 239k | 546.16 | |
| Ironwood Pharmaceuticals (IRWD) | 1.2 | $130M | 11M | 11.59 | |
| Insys Therapeutics | 1.1 | $125M | 4.4M | 28.63 | |
| Cooper Companies | 1.1 | $123M | 915k | 134.20 | |
| Magellan Health Services | 1.0 | $113M | 1.8M | 61.66 | |
| Allergan Plc pfd conv ser a | 1.0 | $107M | 104k | 1028.99 | |
| WellCare Health Plans | 0.9 | $105M | 1.3M | 78.21 | |
| Achillion Pharmaceuticals | 0.9 | $104M | 9.6M | 10.79 | |
| Mallinckrodt Pub | 0.8 | $94M | 1.3M | 74.63 | |
| Tesaro | 0.8 | $92M | 1.8M | 52.32 | |
| Community Health Systems (CYH) | 0.8 | $90M | 3.4M | 26.53 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $85M | 673k | 125.83 | |
| ImmunoGen | 0.8 | $83M | 6.1M | 13.57 | |
| NuVasive | 0.7 | $81M | 1.5M | 54.11 | |
| Affymetrix | 0.7 | $76M | 7.5M | 10.09 | |
| Glaukos (GKOS) | 0.7 | $72M | 2.9M | 24.69 | |
| McKesson Corporation (MCK) | 0.6 | $69M | 349k | 197.23 | |
| Portola Pharmaceuticals | 0.6 | $67M | 1.3M | 51.45 | |
| Insmed (INSM) | 0.6 | $63M | 3.5M | 18.15 | |
| Loxo Oncology | 0.6 | $62M | 2.2M | 28.45 | |
| Bluebird Bio (BLUE) | 0.6 | $61M | 942k | 64.22 | |
| Dimension Therapeutics | 0.6 | $61M | 5.4M | 11.28 | |
| Dynavax Technologies (DVAX) | 0.5 | $60M | 2.5M | 24.16 | |
| Shire | 0.5 | $51M | 251k | 205.00 | |
| Otonomy | 0.5 | $51M | 1.9M | 27.75 | |
| Array BioPharma | 0.4 | $45M | 11M | 4.22 | |
| Medtronic (MDT) | 0.4 | $45M | 588k | 76.92 | |
| CIGNA Corporation | 0.4 | $41M | 282k | 146.33 | |
| Cerus Corporation (CERS) | 0.4 | $41M | 6.5M | 6.32 | |
| Valeant Pharmaceuticals Int | 0.4 | $40M | 390k | 101.65 | |
| Molina Healthcare (MOH) | 0.3 | $34M | 569k | 60.13 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $35M | 4.4M | 7.85 | |
| Newlink Genetics Corporation | 0.3 | $35M | 955k | 36.39 | |
| Affimed Therapeutics B V | 0.3 | $33M | 4.6M | 7.12 | |
| XenoPort | 0.3 | $32M | 5.8M | 5.49 | |
| Johnson & Johnson (JNJ) | 0.3 | $30M | 292k | 102.72 | |
| Pronai Therapeutics | 0.3 | $30M | 2.0M | 15.04 | |
| UnitedHealth (UNH) | 0.2 | $28M | 238k | 117.64 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $27M | 2.4M | 10.81 | |
| Clovis Oncology | 0.2 | $26M | 730k | 35.00 | |
| Gw Pharmaceuticals Plc ads | 0.2 | $21M | 304k | 69.44 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $20M | 2.3M | 8.68 | |
| Forward Pharma A/s | 0.2 | $18M | 961k | 19.00 | |
| Stryker Corporation (SYK) | 0.2 | $17M | 186k | 92.94 | |
| Cynapsus Therapeutics | 0.2 | $18M | 1.1M | 15.44 | |
| Enanta Pharmaceuticals (ENTA) | 0.1 | $17M | 504k | 33.02 | |
| Xencor (XNCR) | 0.1 | $16M | 1.1M | 14.62 | |
| Pieris Pharmaceuticals | 0.1 | $17M | 7.3M | 2.29 | |
| BioMarin Pharmaceutical (BMRN) | 0.1 | $16M | 149k | 104.76 | |
| Zimmer Holdings (ZBH) | 0.1 | $15M | 147k | 102.59 | |
| Sinovac Biotech | 0.1 | $15M | 2.7M | 5.72 | |
| Galapagos Nv- (GLPG) | 0.1 | $15M | 230k | 62.88 | |
| Cardinal Health (CAH) | 0.1 | $13M | 146k | 89.27 | |
| eHealth (EHTH) | 0.1 | $13M | 1.3M | 9.98 | |
| Synergy Pharmaceuticals | 0.1 | $13M | 2.3M | 5.67 | |
| Natera (NTRA) | 0.1 | $14M | 1.3M | 10.80 | |
| Immunomedics | 0.1 | $12M | 3.8M | 3.07 | |
| Jazz Pharmaceuticals (JAZZ) | 0.1 | $13M | 90k | 140.56 | |
| Nabriva Therapeutics | 0.1 | $13M | 1.3M | 9.62 | |
| Ensign (ENSG) | 0.1 | $11M | 495k | 22.63 | |
| Assembly Biosciences | 0.1 | $11M | 1.4M | 7.51 | |
| Cellectis S A (CLLS) | 0.1 | $11M | 350k | 31.03 | |
| Baxalta Incorporated | 0.1 | $11M | 285k | 39.03 | |
| Abbott Laboratories (ABT) | 0.1 | $9.5M | 211k | 44.91 | |
| Macrogenics (MGNX) | 0.1 | $9.8M | 317k | 30.97 | |
| Vitae Pharmaceuticals | 0.1 | $8.8M | 487k | 18.10 | |
| Incyte Corp. note 1.250 11/1 | 0.1 | $9.3M | 4.3M | 2.19 | |
| Incyte Corp note 0.375%11/1 | 0.1 | $9.2M | 4.3M | 2.16 | |
| Aetna | 0.1 | $7.2M | 67k | 108.12 | |
| Medivation | 0.1 | $7.9M | 163k | 48.34 | |
| Redhill Biopharma Ltd cmn | 0.1 | $7.3M | 565k | 12.88 | |
| Lion Biotechnologies | 0.1 | $7.9M | 1.0M | 7.72 | |
| Marinus Pharmaceuticals | 0.1 | $7.4M | 965k | 7.64 | |
| Sientra | 0.1 | $8.0M | 1.4M | 5.92 | |
| Advaxis | 0.1 | $6.4M | 637k | 10.06 | |
| Fluidigm Corporation convertible cor | 0.1 | $6.4M | 10M | 0.64 | |
| Connecture | 0.1 | $6.3M | 1.7M | 3.61 | |
| Anacor Pharmaceuticals In | 0.1 | $6.0M | 53k | 112.96 | |
| Seres Therapeutics (MCRB) | 0.1 | $5.8M | 167k | 35.09 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $5.3M | 439k | 12.06 | |
| Alimera Sciences | 0.0 | $4.1M | 1.7M | 2.42 | |
| Roka Bioscience | 0.0 | $4.0M | 3.2M | 1.23 | |
| Inotek Pharmaceuticals | 0.0 | $4.8M | 425k | 11.33 | |
| Ascendis Pharma A S (ASND) | 0.0 | $4.1M | 222k | 18.32 | |
| Pernix Therapeutics Holdings | 0.0 | $3.2M | 1.1M | 2.95 | |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $3.1M | 5.2M | 0.60 | |
| Invitae (NVTAQ) | 0.0 | $3.7M | 457k | 8.21 | |
| Biotie Therapies Corp. ads | 0.0 | $3.9M | 269k | 14.35 | |
| Fate Therapeutics (FATE) | 0.0 | $2.3M | 693k | 3.37 | |
| Aduro Biotech | 0.0 | $1.7M | 60k | 28.13 | |
| MannKind Corporation | 0.0 | $653k | 450k | 1.45 | |
| Qlt | 0.0 | $1.3M | 500k | 2.66 | |
| Amarin Corporation (AMRN) | 0.0 | $662k | 350k | 1.89 | |
| Biolinerx Ltd-spons | 0.0 | $1.4M | 1.0M | 1.30 | |
| Mirati Therapeutics | 0.0 | $1.0M | 32k | 31.61 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $645k | 500k | 1.29 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $670k | 500k | 1.34 | |
| Ocular Therapeutix (OCUL) | 0.0 | $1.5M | 155k | 9.37 | |
| Cogentix Medical | 0.0 | $1.3M | 991k | 1.29 | |
| Xtant Med Holdings | 0.0 | $1.3M | 475k | 2.80 | |
| Medigus | 0.0 | $54k | 600k | 0.09 |
